Apple and OpenEvidence Launch Experimental AI Health Chat App to Study User Trust

Apple wanted a clinically grounded partner, and that partner is OpenEvidence.
Apple's Sumbul Desai explained the choice of partner for the study at HLTH in Las Vegas.
Mark

So what actually launched on Sunday?

Mimi

A study, not a product launch. Apple and OpenEvidence are running an experimental AI health chat app where participants ask about things like sleep and heart health, and about vitals or lab results they share.

Mark

What are they trying to learn?

Mimi

Sumbul Desai named it: what builds user trust, how people comprehend the answers, and the quality of the responses.

Mark

Why OpenEvidence as the partner?

Mimi

Desai called it a clinically grounded partner. Daniel Nadler framed it as doctors' favorite brand meeting consumers' favorite brand, peanut butter and jelly.

Luke

That line is a CEO's own characterization. Nobody offered evidence in the reporting that either brand is the most trusted or loved.

Mark

Fair. Is this a sign Apple is building a health chatbot?

Luke

The reporting says it hints at possible new directions for both companies. Hints, not plans. No product commitment was described.

Mimi

And the stated aim is understanding interaction, which is research language.

Luke

What's missing matters too: participant numbers, duration, and how shared data is handled aren't in what we have.

Mark

So what should a reader watch for?

Mimi

Whether findings get published, and whether either company moves toward a consumer product.

  • A public stage in Las Vegas became the launchpad for an experimental AI health chat app, announced at HLTH with little time for the public to weigh in.
  • Users can ask about sleep and heart health or share vitals and lab results, raising the stakes of every answer the app gives.
  • Researchers are working to measure what builds trust, whether people really understand the responses, and how good those responses are.
  • The study has no announced size, duration, or data sources yet, leaving its path toward published findings or a consumer launch still uncertain.

Apple and OpenEvidence have begun a study of an experimental AI health chat app, unveiled on stage at the HLTH conference in Las Vegas. It invites people to bring their questions about sleep, heart health, and even their own vitals or lab results to a conversational assistant, and it asks a quiet but important question: whether such tools can be trusted and understood by the people who use them. For now the effort is framed as inquiry rather than product, a careful look at how ordinary people actually live with machines that talk back about their bodies.

On a stage at the HLTH conference in Las Vegas, Apple and OpenEvidence announced a study built around an experimental health chat app powered by artificial intelligence. Participants can ask about everyday concerns like sleep and heart health, and they can share vitals or lab results if they choose to.

Sumbul Desai, Apple's vice president of health and fitness, said the company's commitment to scientific rigor drove the project. The researchers want to understand how people interact with conversational health chatbots: what builds trust, how people comprehend what they are told, and how good the answers are. Apple wanted a clinically grounded partner, and it found one in OpenEvidence.

OpenEvidence's chief executive, Daniel Nadler, made the case for the pairing at the same event, calling his company the most trusted brand among doctors and Apple the most trusted among consumers, and comparing the combination to peanut butter and jelly.

The study is organized around trust and comprehension rather than a finished product. The source does not yet say how many people will take part, how long it will run, or which devices feed the shared data. What happens next, whether findings get published or either company moves toward a consumer product, remains to be seen.

On Sunday, on a stage at the HLTH conference in Las Vegas, Apple and OpenEvidence announced they were launching a study built around an experimental health chat app powered by artificial intelligence. STAT reported that the announcement hinted at possible new directions for both companies.

The app lets participants ask health questions, such as how to improve their sleep or their heart health. They can also ask about vitals or lab results that they choose to share with it.

Sumbul Desai, Apple's vice president of health and fitness, explained what drove the project. She said the company's commitment to scientific rigor motivated the study, which is meant to better understand how consumers interact with conversational health AI chatbots. Speaking during the partnership announcement, she listed what the researchers are looking at: what builds user trust, how people comprehend the responses they get, and the quality of those responses. She said Apple wanted a clinically grounded partner for the work, and that partner is OpenEvidence.

OpenEvidence's chief executive, Daniel Nadler, spoke at the same event and made the case for the pairing in his own terms. He described OpenEvidence as the most trusted and loved brand and product among doctors, and Apple as the most trusted and loved brand and product among consumers, and especially among health consumers. Bringing the two together, he said, was necessary, and he compared the combination to peanut butter and jelly.

The framing matters because the study is organized around trust and comprehension rather than around a finished product. Apple is positioning the effort as research into how people actually use and understand conversational health tools. The source does not say how many people are taking part, how long the study will run, or which devices or data sources feed the shared vitals and lab results.

What comes next is also open. The thing to watch is whether the study produces published findings about conversational health AI, and whether either company moves from this experiment toward a consumer product.

Apple wanted a clinically grounded partner for a study of what builds user trust, how people comprehend responses, and response quality.
— Sumbul Desai, Apple vice president of health and fitness (paraphrased)
Bringing together the doctors' favorite brand and the consumers' favorite brand is like peanut butter and jelly.
— Daniel Nadler, CEO of OpenEvidence (paraphrased)
Möchten Sie die ganze Geschichte? Das Original lesen bei STAT ↗
Kontakt FAQ